Tag Archives: Drug spend

Can Emerging Markets Emerge Fast Enough?

By Ben Comer | Published: July 12, 2012
The IMS Institute’s annual report on global drug spending predicts a slight rebound in developed markets, despite historically low growth rates. In emerging markets, growth continues to be robust, but is it enough to balance the ongoing stagnancy in Europe and the US?
Posted in Emerging Markets, Europe, Global, Market Access, Strategy, leadership, pricing | Also tagged , , , , | Leave a comment

Obamacare's Effect on Drug Spending

By Ben Comer | Published: April 4, 2012
Provisions in the Affordable Care Act (ACA) drove out-of-pocket costs down, while increasing drug spending among 19 to 25-year-olds in 2011, according to research published on Wednesday. The decline observed in overall out-of-pocket spending last year was the “first on record,” and was “largely related to the introduction of the ‘donut-hole’ subsidy for Medicare Part D [...]
Posted in FDA, R&D, Regulatory, Sales, Strategy, healthcare, patient compliance, patient education | Also tagged , , | Leave a comment